Statistics

Total Visits

Views
Progression-Free Survival at 24 Months (PFS24) and Complete Response at 30 Months (CR30) from Autologous Stem Cell Transplantation (ASCT) Should be Used As Surrogates for OS in Follicular Lymphoma (FL) Patients39

Select a period of time:

Number of views in the range

Views
Progression-Free Survival at 24 Months (PFS24) and Complete Response at 30 Months (CR30) from Autologous Stem Cell Transplantation (ASCT) Should be Used As Surrogates for OS in Follicular Lymphoma (FL) Patients2

Views

Views
September 20250
October 20250
November 20252
December 20250
January 20260
February 20260
March 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
Argentina1
Brazil1
 

Top cities views

Views
João Lisboa1
Quilmes1